Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Washington University School of Medicine
Massachusetts General Hospital
University of Nebraska
OHSU Knight Cancer Institute
Herlev Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Arizona
Case Comprehensive Cancer Center
Stanford University
Stanford University
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Stanford University
Istituto Clinico Humanitas
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center